Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Motor Activity 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Vomiting 1 Pathologic Processes 1 Neoplasms 1 Nausea 1 Malnutrition 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Liver Diseases 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Frailty 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1

Interventions

pembrolizumab 38 Bevacizumab 23 Cyclophosphamide 22 Standard of Care 18 Blood Specimen Collection 17 Carboplatin 16 Paclitaxel 15 Nivolumab 14 Gemcitabine 14 Pemetrexed 13 Exercise 13 Cisplatin 12 atezolizumab 11 Radiotherapy 11 Fluorouracil 11 Doxorubicin 11 Surveys and Questionnaires 9 Rituximab 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Cetuximab 9 Biopsy 9 130-nm albumin-bound paclitaxel 9 durvalumab 8 abemaciclib 8 Docetaxel 8 olaparib 7 Temozolomide 7 Prednisone 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Control Groups × 90 days × Clear all

NCT06300515 2026-03-17

Henkō

Universidad Europea de Madrid

Phase NA Recruiting

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡